THE QUALITY AND OUTCOMES FRAMEWORK FOR 2023/24 REWARDS GENERAL PRACTICE FOR IMPROVED CHOLESTEROL MANAGEMENT

STEP BY STEP GUIDE: CONSIDERATIONS FOR GETTING STARTED ON QOF

CONSIDER RESOURCE ALLOCATION AND REPORTING TIMELINES FOR QOF CHOL001 AND CHOL00

CASE STUDY EXAMPLE OF A PATIENT PATHWAY FOR LIPID MANAGEMENT IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE

ESC/EAS GUIDELINES SUPPORT A LOWER IS BETTER APPROACH WITH COMBINATION THERAPY TO REDUCE CV RISK IN UNCONTROLLED PATIENTS

STATINS ARE RECOMMENDED AS FIRST LINE TREATMENT FOR PATIENTS WITH RAISED CHOLESTEROL BUT ARE OFTEN INSUFFICIENT TO ACHIEVE LIPID TARGETS

AROUND 70% OF HIGH-RISK ASCVD PATIENTS USING MODERATEOR HIGH-INTENSITY STATINS ARE NOT REACHING THE LDL-C TREATMENT GOAL OF < 1.8MMOL/L

BEMPEDOIC ACID AND BEMPEDOIC ACID+EZETIMIBE ARE AVAILABLE FOR USE IN PRIMARY CARE: THEY DO NOT REQUIRE INITIATION BY SPECIALIST SERVICES

MANAGE YOUR PATIENTS’ LIPIDS IN PRIMARY CARE WHERE POSSIBLE TO AVOID THE NEED FOR SECONDARY CARE REFERRAL

EMIS®: WHERE TO FIND SEARCHES FOR CHOL001 AND CHOL002

EMIS®: WHERE TO FIND SEARCHES FOR CHOL001 AND CHOL002

ARDENS® EXEMPLAR SEARCH WITHIN EMIS WEB®: WHERE TO FIND SEARCHES FOR CHOL001 AND CHOL002

SYSTMONE® END OF YEAR EXEMPLAR SEARCH: WHERE TO FIND SEARCHES FOR CHOL001 AND CHOL002

SYSTMONE® HOW AM I DRIVING? EXEMPLAR SEARCH: WHERE TO FIND SEARCHES FOR CHOL001 AND CHOL002